Drug intelligence / Profile preview

Transferon

Development stage
Phase 3
Lead developer
Instituto Politécnico Nacional
Modality
Peptides
Administration
Oral, Subcutaneous
01

Overview

Transferon is a human dialyzable leukocyte extract (hDLE) developed by the National Polytechnic Institute (IPN) of Mexico. It is a complex biologic product composed of low-molecular-weight peptides (less than 10 kDa) obtained from the dialysis of disintegrated human leukocytes. Transferon acts as an immunomodulator by promoting the cellular immune response, specifically by inducing the production of Th1 cytokines such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), and by increasing the activity of natural killer (NK) cells and T-lymphocytes. It is used as an adjuvant therapy for various conditions involving immune dysregulation, including infectious diseases (such as herpes zoster and hepatitis), allergic disorders (like atopic dermatitis and asthma), and certain types of cancer.

Brand names
TransferonTransferon Oral
Other names
Factor de TransferenciaHuman Dialyzable Leukocyte ExtracthDLE
02

Targets

IFNG (Interferon gamma)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Transferon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transferon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call